Literature DB >> 15465081

Familial amyotrophic lateral sclerosis with His46Arg mutation in Cu/Zn superoxide dismutase presenting characteristic clinical features and Lewy body-like hyaline inclusions.

Takekazu Ohi1, Kazuki Nabeshima, Shinsuke Kato, Shogo Yazawa, Shinji Takechi.   

Abstract

We evaluated the characteristic clinical features of one family of familial amyotrophic sclerosis (FALS) with a His46Arg mutation in the enzyme Cu/Zn superoxide dismutase (SOD1). Codon 46 encodes the binding site for copper and the His46Arg mutation may result in decreased copper binding and copper toxicity. The disease duration of this family was 17.8+/-13.2 years (mean+/-S.D.) with the age at onset being 42.9+/-4.7 years old (mean+/-S.D.). The initial sign was distal weakness of the unilateral lower limb, extending to the other lower limb. An autopsy was performed on a 62-year-old female member of the family who had the mutation. Her disease duration was 23 years, and she died of tonsillar herniation caused by metastasis of colon cancer in the cerebellum. Neuropathological findings showed marked loss of large anterior horn cells and very mild degeneration of corticospinal tracts as well as posterior columns. The number of nuclei of Clark's column was reduced. Lewy body-like hyaline inclusion bodies (LBHIs) were frequently seen in the remaining anterior horn cells. Astrocytic hyaline inclusions (Ast-HIs) were also seen. This is the first autopsy report of FALS with a His46Arg mutation presenting neuronal LBHIs and Ast-HIs. The formation of LBHIs and Ast-HIs may be dependent on the phenotype of the preferential lower motor neuron involvement in FALS with a SOD mutation and long disease duration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465081     DOI: 10.1016/j.jns.2004.06.008

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

1.  AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.

Authors:  Marcel F Leyton-Jaimes; Joy Kahn; Adrian Israelson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-01       Impact factor: 11.205

2.  Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation.

Authors:  Anna-Lena Ström; Ping Shi; Fujian Zhang; Jozsef Gal; Renee Kilty; Lawrence J Hayward; Haining Zhu
Journal:  J Biol Chem       Date:  2008-05-30       Impact factor: 5.157

3.  Modulating the Effects of the Bacterial Chaperonin GroEL on Fibrillogenic Polypeptides through Modification of Domain Hinge Architecture.

Authors:  Naoya Fukui; Kiho Araki; Kunihiro Hongo; Tomohiro Mizobata; Yasushi Kawata
Journal:  J Biol Chem       Date:  2016-10-14       Impact factor: 5.157

Review 4.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

Review 5.  Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.

Authors:  Sai V Seetharaman; Mercedes Prudencio; Celeste Karch; Stephen P Holloway; David R Borchelt; P John Hart
Journal:  Exp Biol Med (Maywood)       Date:  2009-07-13

6.  Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants.

Authors:  Christian Münch; Anne Bertolotti
Journal:  J Mol Biol       Date:  2010-04-24       Impact factor: 5.469

7.  Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS.

Authors:  Magdalena I Ivanova; Stuart A Sievers; Elizabeth L Guenther; Lisa M Johnson; Duane D Winkler; Ahmad Galaleldeen; Michael R Sawaya; P John Hart; David S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-16       Impact factor: 11.205

8.  Structural and dynamic aspects related to oligomerization of apo SOD1 and its mutants.

Authors:  Lucia Banci; Ivano Bertini; Mirela Boca; Vito Calderone; Francesca Cantini; Stefania Girotto; Miguela Vieru
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-14       Impact factor: 11.205

9.  SOD1 and amyotrophic lateral sclerosis: mutations and oligomerization.

Authors:  Lucia Banci; Ivano Bertini; Mirela Boca; Stefania Girotto; Manuele Martinelli; Joan Selverstone Valentine; Miguela Vieru
Journal:  PLoS One       Date:  2008-02-27       Impact factor: 3.240

10.  Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.

Authors:  Qi Wang; Joshua L Johnson; Nathalie Y R Agar; Jeffrey N Agar
Journal:  PLoS Biol       Date:  2008-07-29       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.